Future Medicine - Women's Health - re: EVA trial (full free access to commentary/abstract of original paper) MRI high risk familial risk breast cancer

link: 

Screening of women at high familial risk of breast cancer

Steven A Narod
 
Evaluation of:  Kuhl C, Weigel S, Schrading S et al.: Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J. Clin. Oncol. 28, 1450–1457 (2010).

"In the EVA trial, Kuhl et al. screened 687 women at high risk of breast cancer for up to 3 years with annual MRI. A total of 27 breast cancers were diagnosed, including 11 DCIS and two local recurrences. There were no interval cancers. This data suggests that MRI screening can be used to downstage breast cancers, but larger studies with longer follow-up periods are required to confirm these findings."

The original paper-link to abstract:
Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial

Women's Health - Review: Acupuncture in reproductive medicine (abstract)

full free access- Women's Health - 21st European Congress of Obstetrics and Gynaecology

full free access: - Women's Health - Ovarian cancer biomarker screening: still too early to tell

"In 2004, the US Preventive Services Task Force (amongst other countries/guidelines) recommended against routine ovarian cancer screening [102]. None of the more recent findings overide this guideline. We must await the results of the two large-scale trials. Whether the results are positive or not, these trials will yield vital data to guide the next steps in biomarker research and subsequent guidelines for practice."